Clinical Trial

The Ailliance Post-Market Clinical Study

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2023-05-09; most recent amendment 2026-06-29.
Trial Details
NCT Number NCT05856370
Lead Sponsor Medtronic Spinal and Biologics
Collaborators: Medtronic Cardiac Rhythm and Heart Failure
Conditions Spinal Deformity, Spinal Degenerative Disorder, Spinal Fusion Failure, Spinal Trauma, Spinal Tumor Case
Enrollment 1,000 participants
Start Date 2023-05-01
Primary Completion 2031-05 (estimated)
Study Completion 2031-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-04